Inventor · disambiguated record
Arvinder Sran
Also filed as: SRAN ARVINDER
25 granted patents·12 pending applications·207 citations·filing 2007–2024
96Inventor score
Top patents by PatentIndex Score
37 records- 0196US8415365B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Apr 9, 2013·31 cites·20 claims
- 0296US7915273B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Mar 29, 2011·33 cites·2 claims
- 0395US8399472B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Mar 19, 2013·26 cites·4 claims
- 0495US8193197B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2007·Granted Jun 5, 2012·17 cites·38 claims
- 0594US9181200B2Pyrimidinedione compoundsMYOKARDIA INC·Filed 2014·Granted Nov 10, 2015·22 cites·19 claims
- 0693US9199945B2Cycloalkyl-substituted pyrimidinedione compoundsMYOKARDIA INC·Filed 2014·Granted Dec 1, 2015·12 cites·20 claims
- 0793US8299087B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Oct 30, 2012·11 cites·4 claims
- 0892US9925177B24-methylsulfonyl-substituted piperidine urea compoundsMYOKARDIA INC·Filed 2016·Granted Mar 27, 2018·16 cites·35 claims
- 0991US11198689B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Dec 14, 2021·2 cites·18 claims
- 1089US8815848B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 26, 2014·8 cites·5 claims
- 1188US9732073B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·4 cites·17 claims
- 1288US2024382486A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2024·Application pending·0 cites
- 1387US10421752B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Sep 24, 2019·3 cites·14 claims
- 1487US9585883B2Pyrimidinedione compoundsMYOKARDIA INC·Filed 2015·Granted Mar 7, 2017·5 cites·18 claims
- 1585US11123337B24-methylsulfonyl-substituted piperidine urea compoundsMYOKARDIA INC·Filed 2020·Granted Sep 21, 2021·1 cites·14 claims
- 1685US9481654B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Nov 1, 2016·5 cites·19 claims
- 1785US9248190B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·4 cites·7 claims
- 1885US2025275952A14-methylsulfonyl-substituted piperidine urea compoundsMYOKARDIA INC·Filed 2024·Application pending·0 cites
- 1983US10758525B24-methylsulfonyl-substituted piperidine urea compoundsMYOKARDIA INC·Filed 2018·Granted Sep 1, 2020·1 cites·36 claims
- 2083US2023165860A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2023·Application pending·0 cites
- 2181US9593082B2Compositions and methods for inhibition of the JAK pathwayARGADE ANKUSH·Filed 2008·Granted Mar 14, 2017·3 cites·17 claims
- 2280USRE50050EPyrimidinedione compoundsMYOKARDIA INC·Filed 2022·Granted Jul 23, 2024·0 cites·23 claims
- 2380US11827628B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Nov 28, 2023·0 cites·19 claims
- 2479US8962643B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2007·Granted Feb 24, 2015·3 cites·25 claims
- 2574US2021346379A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2021·Application pending·0 cites
- 2673US2022117955A14-methylsulfonyl-substituted piperidine urea compoundsMYOKARDIA INC·Filed 2021·Application pending·0 cites
- 2772US2020297726A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2020·Application pending·0 cites
- 2870US11667611B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Jun 6, 2023·0 cites·19 claims
- 2968US9040543B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted May 26, 2015·0 cites·17 claims
- 3065US2018311242A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2018·Application pending·0 cites
- 3162US2007203161A1Compositions and methods for inhibition of the jak pathwayRIGEL PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3262US2017281626A1Pyrimidinedione compoundsMYOKARDIA INC·Filed 2017·Application pending·0 cites
- 3360US8729087B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2012·Granted May 20, 2014·0 cites·22 claims
- 3459US2017121291A1Compositions and methods for inhibition of the jak pathwayRIGEL PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3551US2016031862A1Cycloalkyl-substituted pyrimidinedione compoundsMYOKARDIA INC·Filed 2015·Application pending·0 cites
- 3643US2014113931A1Substituted picolinamide kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 3734US10040766B2Ubiquitination inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 7, 2018·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Arvinder Sran files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →